The results
of this original study are highly relevant to other human diseases that dependent on genome instability, such as fungal infection or cancer, and open new venues for anti-leishmanial drug discovery using host - directed strategies that
target the parasite's metabolic dependence on the host cell, thus preventing the
adaptive evolution of drug resistant parasites.